does medi cal cover glp 1 for weight loss drugs BREAKING: Medi-Cal Ends Coverage Ozempic, Wegovy, Mounjaro & All GLP-1 Weight-Loss Jan 1, 2026, Sacramento, CA 🚨 Medi-Cal patients — important

Neuroprotection in rats following ischaemia-reperfusion injury by Glp-1 analogues-liraglutide and semaglutide

The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease

New Microbes New Infect 42:100897

These results were arrived at by data-fishing techniques, but a more recent, small RCT of people with alcohol use disorder found that nine weeks of low-dose semaglutide (0.251 mg/week) reduced the main outcome of interest: average alcohol consumption (Hendershot CS et al, JAMA Psychiatry

Athletic performance support Athletes and fitness enthusiasts use Lipo-C to support training and body composition goals

A., Hatfield, D